Cas:39929-79-8 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol manufacturer & supplier

Chemical Name:7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol

CAS.NO:39929-79-8

Synonyms:1H-Pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione;2,4-Dihydroxypyrrolo[2,3-d]pyrimidine;2,4-hydroxy-7H-pyrrolo-[2,3-d]pyrimidine;1,7-dihydropyrrolo[2,3-d]pyrimidine-2,4-dione;7-Deazaxanthine;T56 BM GN INJ FQ HQ;T56 BM FVMVMJ;7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol

Molecular Formula:C₆H₅N₃O₂

Molecular Weight:151.123

HS Code:2933990090

Physical and Chemical Properties:

Melting point:>250ºC

Boiling point:607.6±58.0 °C at 760 mmHg

Density:1.8±0.1 g/cm3

Index of Refraction:1.863

PSA:82.03000

Exact Mass:151.038177

LogP:-1.03

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-Pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-hydroxy-7H-pyrrolo-[2,3-d]pyrimidine Use and application,2,4-Dihydroxypyrrolo[2,3-d]pyrimidine technical grade,usp/ep/jp grade.

Related News: After nearly ten years of growth, China’s fine chemical industry has made considerable progress. At present, China’s overall refinement rate (that is, the output value rate of fine chemicals = total value of fine chemical products / total value of chemical products * 100%) has reached about 40%. Some fine chemical products have certain international competitiveness and become important processing and exporting places of fine chemical raw materials and intermediates in the world. 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol manufacturer The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol supplier Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol vendor Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei. 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol factory Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.